3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Brain Neoplasms
12
Supratentorial Neoplasms
2
Meningioma
2
Delirium
2
Stroke
1
Spinal Cord Neoplasms
1
Seizures
1
Pain, Postoperative
1
Pain
1
Neuroinflammatory Diseases
1
Neurofibromatosis 1
1
Neurocognitive Disorders
1
Neoplasms
1
Hypoxia
1
Hemorrhage
1
Glioma
1
Glioblastoma
1
Epilepsy
1
Emergence Delirium
1
Central Nervous System Vascular Malformations
1
Central Nervous System Diseases
1
Arteriovenous Malformations
1
Aneurysm
1
Interventions
Levetiracetam
6
perampanel
2
Tranexamic Acid
2
Standard of Care
2
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tobramycin
1
Temozolomide
1
Spironolactone
1
Sodium Chloride
1
Sevelamer
1
Saline Solution
1
Rocuronium
1
Pregabalin
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Mental Status and Dementia Tests
1
Magnetic Resonance Spectroscopy
1
Magnesium Sulfate
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Seizures
×
Saline Solution
×
CNS
×
Clear all
NCT04595786
2025-03-04
STAMP
Beijing Tiantan Hospital
Phase NA
Completed
228 enrolled